Team & Partner
B10: Cellular plasticity driven by innate immune activation in DDX41-mediated myeloid malignancies
B09: Inflammation-driven plasticity in disease progression in Advanced Systemic Mastocytosis
B08: Spatial and epigenetic plasticity during leukemia development
B07: Single cell multi-omics to unravel niche plasticity in AML therapy resistance
B06: Leukemia cell plasticity and NK cell activity as determinants of relapse in AML
B05: Characterizing lineage plasticity of KMT2A/AFF1-rearranged acute leukemia under therapeutic pressure from CAR T cells
B04: Dissecting mechanisms of immunotherapy-induced plasticity in AML through multi-omics and genome-wide CRISPR screens
B03: Multi-modal proteomics to understand and overcome nicherelatedadaptive drug-resistance mechanisms in FLT3-mutated AML
B02: Investigation into the plastic state of dormancy in JAK2-V617F driven myeloproliferative neoplasms (MPNs) and secondary acute myeloid leukemias (sAMLs)
B01: Predicting response to venetoclax/azacitidine in AML by determining cytologic variability in AML blasts with generative AI image analysis combined with single-celltranscriptomics
Archisman Maitra
Bahar Orhan
Prof. Dr. Axel Roers
Lisa Sippl
Jiefu Zhu
Prof. Dr. Judith Zaugg
Prof. Dr. Carsten Müller-Tidow
Alexander Wahl
Dr. Maria-Luisa Schubert
Dr. Hannah Uckelmann
Prof. Dr. Andreas Reiter
Dr. Tim Sauer
Dr. Andrea Schmidts
Dr. Michael Milsom
Dr. Caroline Pabst
Prof. Dr. Daniel Nowak
Prof. Dr. Jakob Nikolas Kather
Prof. Dr. Jeroen Krijgsveld
Dr. Konstantinos Kokkaliaris
Dr. Ashok Kumar Jayavelu
Dr. Simon Haas
Dr. Simone Feurstein
Dr. Marieke Essers
Prof. Dr. Adelheid Cerwenka
Dr. Dr. Franziska Blaeschke
Dr. Maximilian Felix Blank
